GAA-<i>FGF14</i> ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment responseCarlo Wilke, Matthis Synofzik, David Pellerin et al.|Brain|2023Cited by 114
A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patientsChiara Pane, Francesco Saccà, Claudia Vinciguerra et al.|Journal of Neurology|2024Cited by 49